Acid Secretion Following Portacaval Shunting
Philip Newman
Abstract
Philip Newman
Abstract
Although certain facts have been demonstrated experimentally about gastric hypersecretion in dogs following portacaval transposition, the exact cause remains unclear. 1,2 Hypersecretion has been shown to occur independently of hepatic parenchymal damage 3 is not suppressed by elimination of the cephalic and antral phases of gastric secretion. 4,5 Decreased hepatic catabolism or inactivation of a gastric secretagogue elaborated in the small intestine has been suggested by some investigators, 5-8 and histamine has been suggested to be this secretagogue. 9 Day and associates 10 have shown increased levels of circulating and gastric mucosal histamine in rats with portacaval shunts. Recently, Fischer and Snyder 11,12 have shown increased enzymatic activity of histidine decarboxylase in the gastric mucosa of rats with portacaval shunts and have been able to inhibit the gastric hypersecretion following portacaval shunt with brocresine (NSD-1055), a histidine decarboxylase inhibitor. The changes in gastric secretion brought about by portacaval shunting have
OpenAlex reports 11 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Although certain facts have been demonstrated experimentally about gastric hypersecretion in dogs following portacaval transposition, the exact cause remains unclear. 1,2 Hypersecretion has been shown to occur independently of hepatic parenchymal damage 3 is not suppressed by elimination of the cephalic and antral phases of gastric secretion. 4,5 Decreased hepatic catabolism or inactivation of a gastric secretagogue elaborated in the small intestine has been suggested by some investigators, 5-8 and histamine has been suggested to be this secretagogue. 9 Day and associates 10 have shown increased levels of circulating and gastric mucosal histamine in rats with portacaval shunts. Recently, Fischer and Snyder 11,12 have shown increased enzymatic activity of histidine decarboxylase in the gastric mucosa of rats with portacaval shunts and have been able to inhibit the gastric hypersecretion following portacaval shunt with brocresine (NSD-1055), a histidine decarboxylase inhibitor. The changes in gastric secretion brought about by portacaval shunting have
Key concepts: Portacaval shunt, Medicine, Internal medicine, Portacaval anastomosis, Histidine decarboxylase, Histamine, Endocrinology, Shunting